UBS analyst Karl Keirstead lowered the firm’s price target on DocuSign (DOCU) to $75 from $85 and keeps a Neutral rating on the shares post the Q3 report. The firm says the company’s outlook “falls a bit short.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU: